Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

3 Financial Stocks to Secure a Growing $10K Income Stream

Published 2019-09-08, 09:15 a/m
Updated 2019-09-08, 09:35 a/m
© Reuters.

Hello there, Fools. I’m back to highlight three top dividend-growth stocks. As a quick reminder, I do this because businesses with consistently increasing dividend payouts

  • can guard against the harmful effects of inflation by providing a rising income stream; and
  • tend to outperform the market averages over the long haul.

This week, we’ll take a look at dividend stocks coming from the particularly attractive financial services space.

Bank on it Leading off our list is financial services giant Bank of Montreal (TSX:BMO)(NYSE:BMO), which has delivered steady dividend growth of 30% over the past five years.

BMO’s scale, comfy regulatory environment, and diversified nature continue to support steady payout increases. In the most recent quarter, adjusted EPS clocked in at $2.38 as revenue improved 5%. BMO’s Canadian and U.S. personal and commercial banking businesses combined delivered 9% growth in pre-provision pre-tax profit.

Our capital position remains strong at 11.4% and we are taking actions to continue to position our businesses for growth and sustainable long-term performance,” said CEO Darryl White.

BMO shares are down 8% over the past three months and currently offer a healthy dividend yield of 4.4%.

Keep it intact With steady dividend growth of 55% over the past five years, property and casualty (P&C) insurance company Intact Financial (TSX:IFC) is next up on our list.

As Canada’s largest P&C insurance company, Intact’s scale advantages (close to $10 billion in annual premiums written), multi-channel distribution, and in-house claims expertise should continue to underpin its rising dividend. In Q2, EPS came in at $1.44 as revenue improved 8% to $3.2 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Intact ended the quarter with $1.3 billion of total capital margin.

“Hard market conditions continue across the business allowing us to capture growth opportunities,” said CEO Charles Brindamour.

Intact is up 31% so far in 2019 and currently offers a decent dividend yield of 2.3%.

Imperial choice Rounding out our list is banking behemoth Canadian Imperial Bank of Commerce (TSX:CM)(NYSE:CM), which has increased its dividend 40% over the past five years.

CIBC’s long history of earnings and payout growth coupled with the recent sluggishness of its shares make it a particularly timely play. In the most recent quarter, adjusted earnings improved 4% as revenue grew to $4.7 billion.

“In the third quarter, we delivered solid results through the continued execution of our client-focused strategy,” said CEO Victor Dodig. “Our diversified growth on both sides of the border is a result of a highly connected, purpose-led team working together to meet the needs of our clients.”

CIBC shares remain down about 8% over the past six months and currently offer a healthy dividend yield of 5.4%.

The bottom line There you have it, Fools: three solid dividend-growth stocks worth checking out.

As always, they aren’t formal recommendations. They’re simply a starting point for more research. The breaking of a dividend-growth streak can be especially painful, so plenty of due diligence is still required.

Fool on.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Intact is a recommendation of Stock Advisor Canada.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2019

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This Article Was First Published on The Motley Fool

Latest comments

Cure contre le VIH avec phytothérapie, le docteur Ahmed Usman a guéri mes trois années de VIH avec phytothérapie, je suis tombé sur le témoignage de son patient sur Internet et je l'ai contacté par courrier électronique. Après de nombreuses discussions, il a envoyé sa phytothérapie à mon domicile. et avec sa prescription, j’ai pris le médicament à base de plantes pendant 21 jours, j’ai découvert les modifications sur mon corps, je ne suis plus malade et mes organes sont très actifs, j’ai fait un test et mon résultat a été négatif. Contactez-le pour votre traitement, drahmedusman 5104 @ gmail.com ou Whatsapp / appelez +2348064460510, il a guéri à base de plantes pour le virus de l'herpès et le cancer.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.